Biocompatibility (MTT Test) of Over-The-Counter Palliative Sialagogues
Objectives: To compare in vitro biocompatibility to a variety of over-the-counter, palliative sialagogue (OPS) products. Methods: The pH of commercial OPS products (2 liquid* and 4 lozenges**) were measured (Table): TheraBreath Oral Rinse* (TBOR); Mouth Kote Spray* (MKS); MedActive Oral Relief Lozenges** (MORL); Ludens-Pectic Lozenges** (LPL); Hylamint (Hyaluronic Acid) Lozenge** (HAL); MighTeaFlow Lozenge** (MTFL). Dilutions of phosphate buffered saline (PBS) with media served as control. Liquid products were used as received, lozenges were dissolved in deionized water (1:5 ratio). All solutions were centrifuged at 2000 rpm for 5 min to remove any particulate. Solutions were diluted at 1:1, 1:10, and 1:20 ratios with complete media and pH measured. Dilutions were applied to mouse fibroblast (L929) cells and incubated at 37°C for 72h. N=6/product. Cell mitochondrial succinate dehydrogenase (SDH) activity (MTT testing) was measured on cultures after 72h, and individual plate well results were expressed as a percentage of the appropriate PBS controls. Within a product, percent control values were compared using a 1-way, repeated measures ANOVA. Within a dilution level, percent control values were compared using a 1-way ANOVA. Post-hoc testing by the Tukey test. Pre-set alpha=0.05. Results: Products demonstrated differences in biocompatibility among dilutions. All solutions, except for HAL (original pH 4.4), showed decreased MTT activity at the 1:1 dilution ratio. At 1:10 dilutions, MTT activity increased above control levels, except for TBOR and MORL. At 1:20 dilution, some MTT values decreased relative to the 1:10 value: MTFL, LPL, and HAL, with MKS and MTFL significantly exceeding control. All products demonstrated significantly higher biocompatibility (greater % control) at 1:20 dilution compared to 1:1, except HAL, which was lower. Conclusions: Biocompatibility of over-the-counter palliative sialagogues varies significantly, with diluting resulting in increased biocompatibility. MTT activity did not correlate with initial pH of the solutions.
Division: IADR/AADR/CADR General Session
Meeting:2017 IADR/AADR/CADR General Session (San Francisco, California) Location: San Francisco, California
Year: 2017 Final Presentation ID:2586 Abstract Category|Abstract Category(s):Dental Materials 5: Biocompatibility, Bioengineering and Biologic Effects of Materials
Authors
Messer, Regina
( Georgia Regents University
, Augusta
, Georgia
, United States
)
Fisher, Bailey
( Dental College of Georgia at Augusta University
, Augusta
, Georgia
, United States
)
Hoza, Natalie
( Dental College of Georgia at Augusta University
, Augusta
, Georgia
, United States
)
Humes, Haylee
( Dental College of Georgia at Augusta University
, Augusta
, Georgia
, United States
)
Pike, Ansley
( Dental College of Georgia at Augusta University
, Augusta
, Georgia
, United States
)
Hsu, Stephen
( Dental College of Georgia at Augusta University
, Augusta
, Georgia
, United States
)
Abdelhay, Nancy
( Dental College of Georgia at Augusta University
, Augusta
, Georgia
, United States
)
Rueggeberg, Frederick
( Dental College of Georgia, Augusta University
, Augusta
, Georgia
, United States
)
Support Funding Agency/Grant Number: Travel supported by Thomas P. Hinman/DCG Endowment Fund
Financial Interest Disclosure: NONE
Percent of PBS dilution control value (mean (sd)) for SDH activity among products and dilutions
COMMERCIAL PRODUCT
CONTROL
DILUTION
TBOR
MKS
MTFL
HAL
LPL
MORL
PBS
1:1
10.8 (1.3) A a
13.0 (0.3) AB a
25.5 (2.9) C a
97.0 (9.5) D a
20.3 (6.8) BC a
11.0 (0.9) A a
100.0 (7.7) a
1:10
32.9 (7.0) A b
112.4 (12.5) B b
177.0 (10.3) C c
113.1 (26.8) B a
121.2 (31.0) B c
49.4 (16.3) A b
100.0 (20.5) a
1:20
23.1 (7.0) A ab
117.7 (3.2) D b
125.4 (4.9) D b
77.1 (10.6) C b
63.2 (18.2) BC b
57.3 (9.9) B b
100.0 (41.2) a
ORIGINAL pH
9.7
2.7
6.3
4.4
2.2
2.3
6.5
N= 6 specimens per condition.
Values in cells identified with similar case letters (lower: column, product; upper: row, dilution) are not significantly different.